BioNTech works on its answer to new Covid variant
newsdepo.com
German biotech firm BioNTech has said it has started work on an altered vaccine to fight the Omicron variant of Covid-19, which has significant mutations which may allow it to bypass the protection offered by current jabs. Read Full Article at RT.comBioNTech works on its answer to new Covid variant
German biotech firm BioNTech has said it has started work on an altered vaccine to fight the Omicron variant of Covid-19, which has significant mutations which may allow it to bypass the protection offered by current jabs. Read Full Article at RT.com Read more